world allergy organization guidelines for prevention of allergy and allergic asthma
Skip this Video
Download Presentation
World Allergy Organization Guidelines for Prevention of Allergy and Allergic Asthma

Loading in 2 Seconds...

play fullscreen
1 / 17

world allergy organization guidelines for prevention of allergy ... - PowerPoint PPT Presentation

  • Uploaded on

World Allergy Organization Guidelines for Prevention of Allergy and Allergic Asthma . Editors S.G.O. Johansson Tari Haahtela WAO Project Co-ordinator Karen Henley Davies.

I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
Download Presentation

PowerPoint Slideshow about 'world allergy organization guidelines for prevention of allergy ...' - albert

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
world allergy organization guidelines for prevention of allergy and allergic asthma
World Allergy Organization Guidelines for Prevention of Allergy and Allergic Asthma


S.G.O. Johansson

Tari Haahtela

WAO Project Co-ordinator

Karen Henley Davies

Prevention of Allergy and Allergic Asthma. World Allergy Organisation Project Report and Guidelines. Eds. SGO Johansson and T Haahtela. Chemical Immunology and Allergy. Editors J Ring et al. Vol. 84, Karger, Basel, 2005.

prevention definitions
Prevention, Definitions
  • Primary Prevention: prevention of immunological sensitization (i.e. development of IgE antibodies)
  • Secondary Prevention: preventing development of an allergic disease following sensitization
  • Tertiary Prevention: treatment of allergic diseases and asthma
  • Measures should benefit all, not harm anyone, not involve unreasonable costs
paaa contributors
PAAA Contributors

Innes Asher, New Zealand

Tadd Clayton, New Zealand

Marek L. Kowalski, Poland

Alexander Chuchalin, Russia

Joaquin Sastre, Spain

Matthias Haus, South Africa

Pakit Vichyanond, Thailand

Elif Dagli, Turkey

Adnan Custovic, UK

Stephen T. Holgate, UK

John W. Holloway, UK

Katherine Venables, UK

John Warner, UK

Allen Kaplan, USA

Richard Lockey, USA

Kewin Weiss, USA

Carlos Baena Cagnani, Argentina

Patrick Holt, Australia

Charles Naspitz, Brazil

Nan-Shan Zhong, China

Arne Høst, Denmark

Johannes Ring, Germany

Torsten Schäfer, Germany

Ulrich Wahn, Germany

Michal Hemmo-Lotem, Israel

Benjamin Volovitz, Israel

Attilio Boner, Italy

G. Walter Canonica, Italy

Yoji Iikura, Japan

Joseph Odhiambo, Kenya

genetics current knowledge
GeneticsCurrent knowledge
  • The atopic constitution is a major risk factor for the development of IgE-sensitization
  • Individuals with a family history of atopy have an increased risk of developing allergic diseases
  • Target organ sensitivity is a familial trait
environmental influences on asthma and allergy c urrent knowledge
Environmental Influences on Asthma and Allergy - Current knowledge
  • Cigarette smoking in pregnancy increases the risk of wheezing in infancy
  • Environmental Tobacco Smoke aggravates asthma
  • Allergen avoidance is partially successful (high risk infants)
  • Some early respiratory infections, e.g. pertussis and RSV, may enhance IgE-sensitization
  • Relative lack of early microbial exposure may enhance the development of allergic diseases
early immunological influences current knowledge
Early Immunological InfluencesCurrent knowledge
  • Allergen specific T-helper cell programming is initiated early in life and is driven by ubiquitos dietary and inhalant allergens
  • Early exposure to high levels of dietary allergens results in high zone tolerance
  • Exposure to low levels of inhalant allergens triggers low zone tolerance with weak Th1-like immunity or Th2 polarised response
predictive and early diagnosis current knowledge
Predictive and Early DiagnosisCurrent knowledge
  • Double heredity means a four-fold risk to develop allergies
  • Single heredity means a two-fold risk
  • Early signs of atopic eczema, and presence of IgE antibodies to inhalant allergens, are important risk factors for later respiratory allergy
  • High IgE level in cord blood is specific for subsequent allergic disease but has a low sensitivity
preventive measures guidelines
Preventive MeasuresGuidelines

Primary prevention

  • Avoid smoking and Environmental Tobacco Smoke, particularly during pregnancy and early childhood (B). Remove tobacco smoke from work places (B)
  • Avoid damp housing conditions (C) and reduce indoor air pollutants (C)
  • Breast-feed exclusively until 4-6 months (B*). No special diet for lactating mothers (A)
  • Reduce exposure to inhalant allergens in young children at high risk
  • Eliminate sensitizing and highly irritating agents in occupational environments (C). Implement measures to prevent employee exposure

* WHO: exclusive breast-feeding for 6 months in general

preventive measures guidelines9
Preventive MeasuresGuidelines

Secondary prevention

  • Treat atopic eczema topically, and possibly with systemic pharmacotherapy to prevent respiratory allergy (D)
  • Treat upper airways disease (rhinoconjunctivitis, sinusitis) to reduce risk of asthma (D)
  • In young children sensitized to mites, pets or cockroaches, exposure should be reduced to prevent onset of allergic disease (B)
  • Remove employees from occupational exposure if they have symptoms caused by occupational allergic sensitization (C)
preventive measures guidelines10
Preventive MeasuresGuidelines

Tertiary prevention

  • Infants with cow’s milk allergy avoid cow’s milk proteins; if a supplement is needed, use hypoallergenic formula, if available/affordable, to improve symptom control (B)
  • Patients with asthma, rhinoconjunctivitis or eczema, who are allergic to indoor allergens, should eliminate or reduce the exposure to improve symptom control and prevent exacerbations (A-B)
  • Aim pharmacotherapy primarily towards the underlying inflammatory process (A)
  • Avoid strictly ASA and other non-steroidal anti-inflammatory drugs (NSAID) in patients who are sensitive to them (C)
preventive measures further actions for occupational allergies
Preventive MeasuresFurther actions for occupational allergies
  • Risks of occupational allergy should be monitored and epidemiological information collected by a globally agreed questionnaire
  • High risk allergy environments should be identified. In atopic employees who work in these environments, detection of sensitization by Skin Prick/Puncture Tests or IgE antibody measurements could prevent development of clinical allergy
  • General principles of prevention of occupational allergies should be published by national regulatory and advisory authorities
allergy and asthma education guidelines
Allergy and Asthma EducationGuidelines
  • Patient education regarding precipitants of allergic symptoms, asthma and anaphylaxis is essential. Guided self-management is the key to optimizing disease control (A)
  • School policies on asthma and anaphylaxis management are essential (D)
allergy and asthma education further actions required
Allergy and Asthma EducationFurther actions required

Initiation of an International Coalition for Allergy and Asthma Prevention. The aims are:

  • To collect effective programs in a database for all countries
  • To establish an annual convention on allergy and asthma prevention, education and applied research
  • To establish an International Allergy and Asthma Prevention & Education Promotion Fund
the costs of allergy and asthma guideline
The Costs of Allergy and AsthmaGuideline

Cost of treating allergies and asthma are increasing, switching from hospital costs to medication costs in developed countries

  • When considering any intervention, take into account not only the evidence showing beneficial effect but also the costs
  • Use the most cost-effective product or measure
patient information appendix 1 allergens
Patient Information (Appendix 1)Allergens
  • House dust mite allergen reduction (major strategies, additional strategies)
  • Pollen avoidance
  • Pet allergen avoidance
  • Cockroach allergen avoidance
  • Mould allergen avoidance (indoors, outdoors)
  • Severe reactions, allergic anaphylaxis (schools, work places)
educational programs appendix 2
Educational Programs (Appendix 2)
  • Allergic asthma and rhinitis
  • Atopic eczema/dermatitis
  • Severe Reactions, allergic anaphylaxis (schools, work places)
preventive measures guidelines17
Preventive MeasuresGuidelines


  • Patient education regarding precipitants of asthma, allergic symptoms, and especially anaphylaxis is essential. Guided self-management to prevent, assess and treat symptoms is the key to optimizing disease control (A)
  • School policies on asthma and anaphylaxis management are useful (D)